These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

219 related articles for article (PubMed ID: 24848211)

  • 21. Early reversal of profound rocuronium-induced neuromuscular blockade by sugammadex in a randomized multicenter study: efficacy, safety, and pharmacokinetics.
    Sparr HJ; Vermeyen KM; Beaufort AM; Rietbergen H; Proost JH; Saldien V; Velik-Salchner C; Wierda JM
    Anesthesiology; 2007 May; 106(5):935-43. PubMed ID: 17457124
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A case of anaphylaxis apparently induced by sugammadex and rocuronium in successive surgeries.
    Yamada Y; Yamamoto T; Tanabe K; Fukuoka N; Takenaka M; Iida H
    J Clin Anesth; 2016 Aug; 32():30-2. PubMed ID: 27290941
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Sugammadex rapidly reverses moderate rocuronium- or vecuronium-induced neuromuscular block during sevoflurane anaesthesia: a dose-response relationship.
    Pühringer FK; Gordon M; Demeyer I; Sparr HJ; Ingimarsson J; Klarin B; van Duijnhoven W; Heeringa M
    Br J Anaesth; 2010 Nov; 105(5):610-9. PubMed ID: 20876699
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Sugammadex--a short review and clinical recommendations for the cardiac anesthesiologist.
    Hemmerling TM; Zaouter C; Geldner G; Nauheimer D
    Ann Card Anaesth; 2010; 13(3):206-16. PubMed ID: 20826961
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Efficacy, safety and pharmacokinetics of sugammadex 4 mg kg-1 for reversal of deep neuromuscular blockade in patients with severe renal impairment.
    Panhuizen IF; Gold SJ; Buerkle C; Snoeck MM; Harper NJ; Kaspers MJ; van den Heuvel MW; Hollmann MW
    Br J Anaesth; 2015 May; 114(5):777-84. PubMed ID: 25829395
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effect of reversal of neuromuscular blockade with sugammadex versus usual care on bleeding risk in a randomized study of surgical patients.
    Rahe-Meyer N; Fennema H; Schulman S; Klimscha W; Przemeck M; Blobner M; Wulf H; Speek M; McCrary Sisk C; Williams-Herman D; Woo T; Szegedi A
    Anesthesiology; 2014 Nov; 121(5):969-77. PubMed ID: 25208233
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Anaphylaxis caused by γ-cyclodextrin in sugammadex.
    Hotta E; Tamagawa-Mineoka R; Masuda K; Taura M; Nakagawa Y; Kanehisa F; Tashima S; Katoh N
    Allergol Int; 2016 Jul; 65(3):356-8. PubMed ID: 27062217
    [No Abstract]   [Full Text] [Related]  

  • 28. Efficacy and safety of sugammadex in the reversal of deep neuromuscular blockade induced by rocuronium in patients with end-stage renal disease: A comparative prospective clinical trial.
    de Souza CM; Tardelli MA; Tedesco H; Garcia NN; Caparros MP; Alvarez-Gomez JA; de Oliveira Junior IS
    Eur J Anaesthesiol; 2015 Oct; 32(10):681-6. PubMed ID: 26225497
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Reversal of rocuronium-induced neuromuscular blockade with sugammadex in pediatric and adult surgical patients.
    Plaud B; Meretoja O; Hofmockel R; Raft J; Stoddart PA; van Kuijk JH; Hermens Y; Mirakhur RK
    Anesthesiology; 2009 Feb; 110(2):284-94. PubMed ID: 19194156
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Safety and efficacy of sugammadex for the reversal of rocuronium-induced neuromuscular blockade in cardiac patients undergoing noncardiac surgery.
    Dahl V; Pendeville PE; Hollmann MW; Heier T; Abels EA; Blobner M
    Eur J Anaesthesiol; 2009 Oct; 26(10):874-84. PubMed ID: 19455040
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Reversal of profound rocuronium or vecuronium-induced neuromuscular block with sugammadex in isoflurane-anaesthetised dogs.
    Mosing M; Auer U; West E; Jones RS; Hunter JM
    Vet J; 2012 Jun; 192(3):467-71. PubMed ID: 22030475
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Reversal of profound rocuronium-induced blockade with sugammadex: a randomized comparison with neostigmine.
    Jones RK; Caldwell JE; Brull SJ; Soto RG
    Anesthesiology; 2008 Nov; 109(5):816-24. PubMed ID: 18946293
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Sugammadex: a novel approach to reversal of neuromuscular blockade.
    Aniskevich S; Leone BJ; Brull SJ
    Expert Rev Neurother; 2011 Feb; 11(2):185-98. PubMed ID: 21306205
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effects of sugammadex on incidence of postoperative residual neuromuscular blockade: a randomized, controlled study.
    Brueckmann B; Sasaki N; Grobara P; Li MK; Woo T; de Bie J; Maktabi M; Lee J; Kwo J; Pino R; Sabouri AS; McGovern F; Staehr-Rye AK; Eikermann M
    Br J Anaesth; 2015 Nov; 115(5):743-51. PubMed ID: 25935840
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Recovery from prolonged deep rocuronium-induced neuromuscular blockade: A randomized comparison of sugammadex reversal with spontaneous recovery.
    Rahe-Meyer N; Berger C; Wittmann M; Solomon C; Abels EA; Rietbergen H; Reuter DA
    Anaesthesist; 2015 Jul; 64(7):506-12. PubMed ID: 26126940
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The role of sugammadex in the development and modification of an allergic response to rocuronium: evidence from a cutaneous model.
    Clarke RC; Sadleir PH; Platt PR
    Anaesthesia; 2012 Mar; 67(3):266-73. PubMed ID: 22321083
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Use of sugammadex in patients with a history of pulmonary disease.
    Amao R; Zornow MH; Cowan RM; Cheng DC; Morte JB; Allard MW
    J Clin Anesth; 2012 Jun; 24(4):289-97. PubMed ID: 22608583
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A randomised controlled trial comparing sugammadex and neostigmine at different depths of neuromuscular blockade in patients undergoing laparoscopic surgery.
    Geldner G; Niskanen M; Laurila P; Mizikov V; Hübler M; Beck G; Rietbergen H; Nicolayenko E
    Anaesthesia; 2012 Sep; 67(9):991-8. PubMed ID: 22698066
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Sugammadex reversal of rocuronium-induced neuromuscular blockade: a comparison with neostigmine-glycopyrrolate and edrophonium-atropine.
    Sacan O; White PF; Tufanogullari B; Klein K
    Anesth Analg; 2007 Mar; 104(3):569-74. PubMed ID: 17312210
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Anaphylaxis to sugammadex.
    Savic L; Savic S; Hopkins PM
    Anaesth Intensive Care; 2014 Jan; 42(1):7-9. PubMed ID: 24494255
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.